Document Detail

Attenuation of androgenic regulation by brefeldin A in androgen-responsive prostate cancer cells.
MedLine Citation:
PMID:  21795077     Owner:  NLM     Status:  Publisher    
OBJECTIVES:: To investigate the effects of an antibiotic brefeldin A (BFA) on androgen-regulated cellular events in androgen-responsive prostate cancer cells, focusing on PSA (prostate-specific antigen) status, cell growth, and bioactivity of androgen receptor (AR). MATERIALS AND METHODS:: Androgen-responsive human prostate cancer LNCaP cells were employed and 5α-dihydrotestosterone (DHT) was used as an androgenic mediator to induce androgen-modulated cellular events. Effects of BFA on synthesis and secretion of PSA, cell growth, and AR activity were assessed using Tandem PSA assay, trypan blue exclusion method, and AR binding assay, respectively. RESULTS:: BFA (30 ng/ml) dramatically (90%) blocked secretion of PSA and also reduced cell growth by >75% under non-androgen-regulated condition. Under androgen-stimulated condition using DHT (1 nM), both the cellular and secreted PSA levels as well as cell growth was significantly elevated or stimulated by DHT (compared with controls); however, BFA was capable of completely inhibiting such DHT-stimulated cellular events. In addition, AR binding assay revealed that AR activity has been drastically (∼90%) diminished by BFA, likely resulting in interruption of DHT-mediated events. CONCLUSIONS:: BFA is capable of attenuating androgenic regulation in LNCaP cells such as androgen-stimulated PSA synthesis/secretion and cell growth. This BFA-blocked androgen action appears to be primarily attributed to severe inactivation of AR with BFA because AR is a crucial factor for relaying androgenic messages (to DNA). Therefore, BFA could be considered a promising agent for a more effective treatment of hormone-dependent prostate cancer.
Bobby Alexander; Andrew I Fishman; David Green; Muhammad S Choudhury; Sensuke Konno
Related Documents :
6649157 - The kinetics and mechanics of ultrasonically-induced cell lysis produced by non-trapped...
9062157 - Radiosensitivity patterns of four human ovarian cancer cell lines in vitro.
7738407 - Effects of topoisomerase i-targeted drugs on radiation response of l5178y sublines diff...
15692547 - Curcumin: a new radio-sensitizer of squamous cell carcinoma cells.
9600087 - Protein kinase c isoform expression and function in transformed and non-transformed pan...
10762597 - Reprogramming erythroleuekmia cells to terminal differentiation and terminal cell divis...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-7-25
Journal Detail:
Title:  Urologic oncology     Volume:  -     ISSN:  1873-2496     ISO Abbreviation:  -     Publication Date:  2011 Jul 
Date Detail:
Created Date:  2011-7-28     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9805460     Medline TA:  Urol Oncol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011 Elsevier Inc. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Candidacy for active surveillance may be associated with improved functional outcomes after prostate...
Next Document:  Pretreatment depressive symptoms and treatment modality predict post-treatment disease-specific qual...